Drs. Ben Solomon, Leora Horn, & Jack West consider whether immunotherapy might prove to be more problematic when given to a broader population of older and frail patients with advanced lung cancer.
Advertisement
Are Immune Checkpoint Inhibitors Sufficiently Tolerable to Recommend Them for Older Patients_ [360p]
By Editor